<-- Interviews with leading Life Sciences companies: Oncolys BioPharma Inc. -->
Co-founded with Prof. Toshiyoshi Fujiwara1, the
inventor of the telomerase specific oncolytic adenovirus
technology, Oncolys BioPharma is committed to make its
therapeutic and diagnostic products available for patients with
intractable cancers.
Venture Valuation (VV) interviewed Yasunari Kashihara, Vice President, Business
Development, and Kohei Hata, Deputy Director, Corporate Development